Related references
Note: Only part of the references are listed.Study of Circulating MicroRNA-125b Levels in Serum Exosomes in Advanced Melanoma
Estibaliz Alegre et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study
Eyal Greenberg et al.
BIOMARKERS (2013)
Circulating microRNAs predict biochemical recurrence in prostate cancer patients
L. A. Selth et al.
BRITISH JOURNAL OF CANCER (2013)
Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays
Jiayu Feng et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype
A. Rio-Machin et al.
LEUKEMIA (2013)
Sensitive detection of melanoma metastasis using circulating microRNA expression profiles
Rie Shiiyama et al.
MELANOMA RESEARCH (2013)
Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation
Paola de Candia et al.
PLOS ONE (2013)
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
Gianpiero Di Leva et al.
PLOS GENETICS (2013)
SERPINE1 expression discriminates site-specific metastasis in human melanoma
R. Matthew Klein et al.
EXPERIMENTAL DERMATOLOGY (2012)
Serum microRNAs as biomarkers for recurrence in melanoma
Erica B. Friedman et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins
Vasco Liberal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-30b/30d Regulation of GaINAc Transferases Enhances Invasion and Immunosuppression during Metastasis
Avital Gaziel-Sovran et al.
CANCER CELL (2011)
The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
Hisashi Kanemaru et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
Lena M. Wulfken et al.
PLOS ONE (2011)
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Miguel F. Segura et al.
CLINICAL CANCER RESEARCH (2010)
The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients
Rachael L. Morton et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Costs of the detection of metastases and follow-up examinations in cutaneous melanoma
Ulrike Leiter et al.
MELANOMA RESEARCH (2009)
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
C. Monteagudo et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
ADAMs in cancer cell proliferation and progression
Satsuki Mochizuki et al.
CANCER SCIENCE (2007)
Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy
Uma Thanarajasingam et al.
CANCER RESEARCH (2007)
MITF: master regulator of melanocyte development and melanoma oncogene
Carmit Levy et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets
CL Andersen et al.
CANCER RESEARCH (2004)
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease
IM Mullins et al.
CANCER RESEARCH (2004)
The epidemiology of skin cancer
TL Diepgen et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Share Paper
